Christopher P. Borello

Partner, New York

With Fitzpatrick since law school, Chris has learned from some of the most respected attorneys in the field of IP. He has experience asserting and defending patents, with domestic and foreign clients, with cases large and small from inception through trial. Chris has worked on cases involving pharmaceuticals (small molecules, formulations, and methods of treatment), biotechnology, mechanical devices, and computer technology. He recognizes the importance of being responsive and efficient.

In addition to his work in the U.S. District Courts, Chris has experience with contested proceedings in the Patent and Trademark Office, with arbitrations, and in drafting complex settlement agreements.

Prior to joining Fitzpatrick, Chris was an environmental engineer for a national engineering firm. While in law school, he was an editor of the Pace Environmental Law Review.

Chris is the Administrative Partner of the Firm’s New York Office and presently serves on the Firm’s Management Committee.

Case Highlight

Gilead Sciences v. Teva Pharmaceuticals USA, (SDNY)

Gilead (patentee) against a generic drug manufacturer alleging invalidity of patents that cover tenofovir disoproxil fumarate, an active ingredient used in Gilead’s Viread®, Truvada®, Atripla®, Complera®, and Stribild® medicines. The case settled on the eve of trial, with Gilead’s competitor agreeing to stay off the market with its proposed generic products until six weeks before expiration of Gilead's exclusivity period.